HBsAg loss in chronic hepatitis B patients with an HBsAg decline plateau can be enhanced by intermittent PEG-IFN treatment

BackgroundDuring interferon (IFN) treatment patients with chronic hepatitis B (CHB), HBsAg levels often declines to a plateau. This study investigated the HBsAg loss rate in patients receiving continuous IFN treatment after reaching a plateau compared with patients who suspended IFN treatment for 3–...

Полное описание

Библиографические подробности

Главные авторы:	Weihua Cao, Si Xie, Hongxiao Hao, Wen Deng, Lu Zhang, Yao Lu, Ruyu Liu, Shiyu Wang, Xinxin Li, Ziyu Zhang, Xin Wei, Zixuan Gao, Linmei Yao, Shuojie Wang, Yuanjiao Gao, Yujie Wang, Mengjiao Xu, Leiping Hu, Yao Xie, Minghui Li
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2026-05-01
Серии:	Frontiers in Cellular and Infection Microbiology
Предметы:	antiviral therapy chronic hepatitis B HBsAg loss intermittent therapy pegylated interferon
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fcimb.2026.1778016/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!